30.06.2013 Views

How does the operation of PHARMAC's 'Community Exceptional ...

How does the operation of PHARMAC's 'Community Exceptional ...

How does the operation of PHARMAC's 'Community Exceptional ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

medications from <strong>the</strong> service due to cost saving (PB/142w Jocelyn Brooks,<br />

2000).<br />

In a similar vein, Coralee Leyland submitted that when health care is rationed<br />

(as in <strong>the</strong> case <strong>of</strong> PHARMAC rationing <strong>the</strong> supply <strong>of</strong> pharmaceuticals), a<br />

person’s ability to pay becomes an important factor in <strong>the</strong>ir access to care.<br />

Leyland believed <strong>the</strong> NZPHD Bill would accentuate <strong>the</strong> gap between those who<br />

could pay for health care and those who could not (PB/144w Coralee Leyland,<br />

2000).<br />

Ano<strong>the</strong>r submitter, L.A.Smalley an insulin-dependent diabetic, stated that <strong>the</strong>re<br />

were considerable pharmacy costs which diabetics have to bear to stay alive.<br />

Smalley complained that under <strong>the</strong> current regime she was ‘means tested’ 41 to<br />

determine if she was eligible for a state subsidy to cover her extra<br />

pharmaceutical costs. In her own words:<br />

To be diagnosed with diabetes a patient is not means tested, yet to<br />

receive any form <strong>of</strong> treatment a diabetic is subject to a means test.<br />

Diabetes affects not only <strong>the</strong> rich who can afford <strong>the</strong> treatment, but also<br />

<strong>the</strong> poor who cannot afford all <strong>the</strong> ‘necessities’ to ensure a normal life.<br />

(PB/3w Linda Smalley, 2000)<br />

Request by The Ministry <strong>of</strong> Health<br />

Brooks, Leyland and Smalley were effective in <strong>the</strong>ir submissions. The Ministry<br />

<strong>of</strong> Health made a submission which dealt with <strong>the</strong>ir concerns by recommending<br />

that a provision be added to <strong>the</strong> Bill which allowed PHARMAC to set criteria<br />

under which people may be prescribed certain pharmaceuticals (e.g., Ritalin 42 ).<br />

This provision would be subject to any directions approved by <strong>the</strong> PHARMAC<br />

Board and inserted into PHARMAC’s annual plan (PB/MOH 8 Ministry <strong>of</strong><br />

Health, 2000).<br />

Submission on <strong>the</strong> PHARMAC’s Decision Making<br />

The New Zealand AIDS Foundation (NZAF) raised objections to <strong>the</strong> way<br />

PHARMAC had unfairly functioned in <strong>the</strong> past in relation to its decision making<br />

processes. They submitted that <strong>the</strong> processes used were too slow and<br />

41 To apply a means test in New Zealand is to require an examination <strong>of</strong> a person’s financial circumstances, usually by a<br />

government <strong>of</strong>ficial, to establish whe<strong>the</strong>r that <strong>the</strong> person is able or unable to pay for an essential service or be eligible<br />

for a government subsidy or government funded programme.<br />

42 Ritalin is <strong>the</strong> trade name for Methylphenidate (MPH) is a prescription stimulant commonly used to treat Attention-<br />

Deficit Hyperactivity Disorder (ADHD) in children and adults.<br />

126

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!